Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders PH Lee, V Anttila, H Won, YCA Feng, J Rosenthal, Z Zhu, EM Tucker-Drob, ... Cell 179 (7), 1469-1482. e11, 2019 | 1104 | 2019 |
Shared genetic background between children and adults with attention deficit/hyperactivity disorder P Rovira, D Demontis, C Sánchez-Mora, T Zayats, M Klein, NR Mota, ... Neuropsychopharmacology 45 (10), 1617-1626, 2020 | 111 | 2020 |
Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality M Soler Artigas, C Sánchez-Mora, P Rovira, V Richarte, I Garcia-Martínez, ... Molecular Psychiatry 25 (10), 2493-2503, 2020 | 80 | 2020 |
Structural brain imaging studies offer clues about the effects of the shared genetic etiology among neuropsychiatric disorders NV Radonjić, JL Hess, P Rovira, O Andreassen, JK Buitelaar, CRK Ching, ... Molecular psychiatry 26 (6), 2101-2110, 2021 | 77 | 2021 |
Genetic association study of childhood aggression across raters, instruments, and age HF Ip, CM Van der Laan, EML Krapohl, I Brikell, C Sánchez-Mora, ... Translational psychiatry 11 (1), 413, 2021 | 73 | 2021 |
Epigenetic signature for attention-deficit/hyperactivity disorder: identification of miR-26b-5p, miR-185-5p, and miR-191-5p as potential biomarkers in peripheral blood … C Sánchez-Mora, M Soler Artigas, I Garcia-Martínez, M Pagerols, ... Neuropsychopharmacology 44 (5), 890-897, 2019 | 46 | 2019 |
Genetic overlap and causality between substance use disorder and attention‐deficit and hyperactivity disorder L Vilar‐Ribó, C Sánchez‐Mora, P Rovira, V Richarte, M Corrales, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 186 …, 2021 | 37 | 2021 |
Meta-analysis and systematic review of ADGRL3 (LPHN3) polymorphisms in ADHD susceptibility EM Bruxel, CR Moreira-Maia, GC Akutagava-Martins, TP Quinn, M Klein, ... Molecular psychiatry 26 (6), 2277-2285, 2021 | 27 | 2021 |
Associations of major depressive disorder with chronic physical conditions, obesity and medication use: Results from the PISMA-ep study M Rivera, A Porras-Segovia, P Rovira, E Molina, B Gutiérrez, J Cervilla European psychiatry 60, 20-27, 2019 | 25 | 2019 |
71ATTENTION-DEFICIT/HYPERACTIVITY DISORDER AND LIFETIME CANNABIS USE: GENETIC OVERLAP AND CAUSALITY MS Artigas, C Sánchez-Mora, P Rovira, V Richarte, I García-Martínez, ... European Neuropsychopharmacology 29, S1108, 2019 | 25 | 2019 |
Epigenome-wide association study of attention-deficit/hyperactivity disorder in adults P Rovira, C Sánchez-Mora, M Pagerols, V Richarte, M Corrales, ... Translational psychiatry 10 (1), 199, 2020 | 22 | 2020 |
Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder M Pagerols, V Richarte, C Sánchez-Mora, P Rovira, M Soler Artigas, ... Scientific reports 8 (1), 1881, 2018 | 21 | 2018 |
Mendelian randomization analysis for attention deficit/hyperactivity disorder: studying a broad range of exposures and outcomes M Soler Artigas, C Sánchez-Mora, P Rovira, L Vilar-Ribó, ... International journal of epidemiology 52 (2), 386-402, 2023 | 17 | 2023 |
Gene-wide Association Study Reveals RNF122 Ubiquitin Ligase as a Novel Susceptibility Gene for Attention Deficit Hyperactivity Disorder I Garcia-Martínez, C Sánchez-Mora, M Soler Artigas, P Rovira, ... Scientific reports 7 (1), 5407, 2017 | 16 | 2017 |
Transcriptome profiling in adult attention-deficit hyperactivity disorder N Mortimer, C Sanchez-Mora, P Rovira, L Vilar-Ribo, V Richarte, ... European Neuropsychopharmacology 41, 160-166, 2020 | 13 | 2020 |
Genome-wide analysis of emotional lability in adult attention deficit hyperactivity disorder (ADHD) L Gisbert, L Vilar, P Rovira, C Sanchez-Mora, M Pagerols, ... European Neuropsychopharmacology 29 (6), 795-802, 2019 | 10 | 2019 |
Toxoplasma gondii Seropositivity Interacts with Catechol-O-methyltransferase Val105/158Met Variation Increasing the Risk of Schizophrenia P Rovira, B Gutiérrez, A Sorlózano-Puerto, J Gutiérrez-Fernández, ... Genes 13 (6), 1088, 2022 | 5 | 2022 |
Correction to: Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality M Soler Artigas, C Sánchez-Mora, P Rovira, V Richarte, I Garcia-Martínez, ... Molecular psychiatry 26 (7), 3663-3663, 2021 | 4 | 2021 |
Schizophrenia polygenic risk score in psychosis proneness P Mas-Bermejo, S Papiol, M Via, P Rovira, P Torrecilla, TR Kwapil, ... European Archives of Psychiatry and Clinical Neuroscience 273 (8), 1665-1675, 2023 | 3 | 2023 |
Influence of BDNF Val66Met genetic polymorphism in Major Depressive Disorder and Body Mass Index: Evidence from a meta-analysis of 6481 individuals AM Pérez-Gutiérrez, P Rovira, B Gutiérrez, JA Cervilla, JA Zarza-Rebollo, ... Journal of Affective Disorders 344, 458-465, 2024 | 2 | 2024 |